Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay
BACKGROUND: This study assessed the Granzyme B (GrB) ELISPOT as a viable alternative to the (51)Cr-release assay for measuring cytotoxic activity of innate immune effector cells. We strategically selected the GrB ELISPOT assay because GrB is a hallmark effector molecule of cell-mediated destruction...
Guardado en:
| Publicado en: | J Transl Med |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2004
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC522821/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15380049/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1479-5876-2-31 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
